DUDIT Calculator
Use our free Duditcalculator Calculator to get personalized health results. Based on validated medical formulas and clinical guidelines.
Formula
Total Score = Sum of Q1-Q9 (0-4 each) + Q10 (0,2,4) + Q11 (0,2,4)
Items 1-9 are scored on a 5-point scale from 0 (never) to 4 (daily/almost daily). Items 10 and 11 use a 3-point scale of 0, 2, or 4. Maximum total score is 44. Higher scores indicate greater severity of drug use problems.
Worked Examples
Example 1: Moderate Risk Screening
Problem: A 32-year-old patient reports using drugs 2-4 times per month (2), using one drug type (0), taking 1-2 doses per occasion (1), being heavily influenced monthly (2), with occasional cravings (1), no loss of control (0), neglecting duties less than monthly (1), no morning use (0), monthly guilt (2), no harm (0), and a friend expressed concern in the past (2).
Solution: Q1=2, Q2=0, Q3=1, Q4=2, Q5=1, Q6=0, Q7=1, Q8=0, Q9=2, Q10=0, Q11=2\nTotal = 2+0+1+2+1+0+1+0+2+0+2 = 11\nFrequency domain (Q1-Q4) = 2+0+1+2 = 5/16\nDependence domain (Q5-Q8) = 1+0+1+0 = 2/16\nHarm domain (Q9-Q11) = 2+0+2 = 4/12
Result: Total Score: 11/44 (25%) | Risk Level: Hazardous Use | Brief intervention recommended
Example 2: High Risk Screening
Problem: A patient uses drugs 2-3 times per week (3), uses multiple drugs (3), takes 5-6 doses (3), is heavily influenced weekly (3), has weekly cravings (3), monthly loss of control (2), weekly neglect (3), monthly morning use (2), weekly guilt (3), has been hurt in the past year (4), and others expressed concern this year (4).
Solution: Q1=3, Q2=3, Q3=3, Q4=3, Q5=3, Q6=2, Q7=3, Q8=2, Q9=3, Q10=4, Q11=4\nTotal = 3+3+3+3+3+2+3+2+3+4+4 = 33\nFrequency domain = 12/16 (75%)\nDependence domain = 10/16 (63%)\nHarm domain = 11/12 (92%)
Result: Total Score: 33/44 (75%) | Risk Level: Probable Dependence | Specialist referral recommended
Frequently Asked Questions
What is the DUDIT screening tool and what does it measure?
The Drug Use Disorders Identification Test (DUDIT) is an 11-item validated screening instrument developed by Anne H. Berman and colleagues at the Karolinska Institute in Stockholm, Sweden. It was designed to parallel the widely used AUDIT questionnaire for alcohol but focuses specifically on drug use disorders. The DUDIT identifies individuals with drug-related problems across a spectrum from hazardous use to probable dependence. Questions cover four domains: frequency and pattern of drug use (items 1-4), dependence symptoms such as craving and loss of control (items 5-8), and drug-related problems including guilt and harm to self or others (items 9-11). Scores range from 0 to 44, with higher scores indicating more severe drug-related problems requiring clinical attention.
How is the DUDIT scored and what do different score ranges indicate?
The DUDIT uses a scoring system where items 1 through 9 are scored from 0 to 4 and items 10 and 11 are scored as 0, 2, or 4, giving a maximum possible score of 44. For men, a score of 6 or higher indicates hazardous drug use warranting further investigation, while for women the threshold is lower at 2 or higher due to gender differences in drug metabolism and vulnerability. Scores above 25 are strongly indicative of drug dependence regardless of gender. The Swedish validation study found that a cutoff score of 8 provided optimal sensitivity of 90 percent and specificity of 78 percent for identifying drug use disorders. Clinical judgment should always supplement screening scores when determining appropriate interventions and referrals.
What is the difference between the DUDIT and the DAST screening tools?
Both the DUDIT and the Drug Abuse Screening Test (DAST) screen for drug use problems, but they differ in structure and approach. The DAST uses 10 or 28 yes/no questions and focuses primarily on consequences of drug use over the past 12 months. The DUDIT uses 11 items with graded response options (frequency-based scales) that capture both the pattern and severity of drug use. The DUDIT was specifically designed to match the format of the AUDIT for alcohol, making it intuitive for clinicians familiar with that tool. The DUDIT also separates consumption patterns from dependence symptoms and harm, providing more nuanced clinical information. Research suggests the DUDIT may be more sensitive in detecting hazardous use before full dependence develops, while the DAST is better established in North American clinical settings.
In what clinical settings is the DUDIT most commonly used?
The DUDIT is used across a wide range of healthcare and social service settings. Primary care clinics use it for routine screening during health checkups, especially when patients present with conditions potentially related to substance use. Emergency departments employ it to identify drug-related presentations that may benefit from brief intervention. Addiction medicine and psychiatry programs use it as part of comprehensive substance use assessments. Criminal justice settings including probation services and drug courts use the DUDIT for risk assessment and treatment matching. Occupational health services may use it in workplace wellness programs. Mental health services use it to screen for co-occurring substance use disorders among patients seeking treatment for depression, anxiety, or other psychiatric conditions.
What are the limitations of the DUDIT and when should additional assessment be performed?
The DUDIT has several important limitations that clinicians should recognize. First, it relies on self-report, which means patients may underreport drug use due to stigma, legal concerns, or lack of insight. Second, the tool does not identify which specific drugs are being used, requiring supplementary questioning for treatment planning. Third, cultural and linguistic factors may affect response patterns, and while the DUDIT has been validated in multiple countries, local norms should be considered. Fourth, the screening tool cannot diagnose a substance use disorder on its own and should always be followed by a comprehensive clinical assessment when scores indicate concern. Additional assessment should include a detailed drug use history, medical and psychiatric evaluation, assessment of social functioning, and consideration of co-occurring mental health conditions which are present in approximately 50 percent of individuals with substance use disorders.
Can I use the results for professional or academic purposes?
You may use the results for reference and educational purposes. For professional reports, academic papers, or critical decisions, we recommend verifying outputs against peer-reviewed sources or consulting a qualified expert in the relevant field.